In this study we evaluated for the first time the prognostic significance of TWIST1, CD24, CD44, and ALDH1 transcript quantification in EpCAM-positive circulating tumor cells isolated from peripheral blood of early stage breast cancer patients. This evidence concerns the gene CD44 and breast cancer.